Latest News

Celgene, following BMS buyout, forms two immuno-oncology partnerships

The company said Friday morning that it would partner with two companies, Kyn Therapeutics and Obsidian Therapeutics.

Source link

Related posts

Women's Longevity, Old-Age Health Could Be Predicted By Mothers' Lifespan


Scientists closer to unraveling mechanisms of speech processing in the brain


Should we rename low risk cancers?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy